ADCT

ADCT

USD

ADC Therapeutics SA Common Shares

$4.040-0.050 (-1.222%)

Real-time Price

Healthcare
Biotechnology
Switzerland

Price Chart

Loading Chart...

Key Metrics

Market Metrics
Company Fundamentals
Trading Stats

Market Metrics

Open

$4.090

High

$4.140

Low

$3.630

Volume

1.21M

Company Fundamentals

Market Cap

454.5M

Industry

Biotechnology

Country

Switzerland

Trading Stats

Avg Volume

0.89M

Exchange

NYQ

Currency

USD

52-Week Range

Low $1.05Current $4.040High $4.8

Related News

PR Newswire

ADC Therapeutics Reports Third Quarter 2025 Financial Results and Provides Operational Update

ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today reported...

View more
ADC Therapeutics Reports Third Quarter 2025 Financial Results and Provides Operational Update
PR Newswire

ADC Therapeutics to Host Third Quarter 2025 Financial Results Conference Call on November 10, 2025

ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced that...

View more
ADC Therapeutics to Host Third Quarter 2025 Financial Results Conference Call on November 10, 2025
PR Newswire

ADC Therapeutics to Present at November Investor Conferences

ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today announced...

View more
ADC Therapeutics to Present at November Investor Conferences